PAID CLINICAL TRIAL
- Lasting 7-8 months
- 8 clinic visits
YOU MAY BE ELIGIBLE TO PARTICIPATE IF YOU MEET THE FOLLOWING CRITERIA:
- Are 18 to 75 years of age
- Diagnosis of Rheumatoid Arthritis
The
purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of multiple ascending doses of GS-015 on an adult participant with rheumatoid arthritis.
Lynn Institute is a leader in introducing new medications to the market through our clinical trials program. Visit our Participation Information page for Frequently Asked Questions, to see current clinical trials listed, and to find out where each trial is being conducted.
Find out More About Our Participation Program
Participation Information